Predictive value of the SLC22A18 protein expression in glioblastoma patients receiving temozolomide therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Predictive value of the SLC22A18 protein expression in glioblastoma patients receiving temozolomide therapy ; volume:11 ; number:1 ; day:20 ; month:3 ; year:2013 ; pages:1-8 ; date:12.2013
Journal of translational medicine ; 11, Heft 1 (20.3.2013), 1-8, 12.2013
- Urheber
-
Chu, Sheng-Hua
- Beteiligte Personen und Organisationen
-
Ma, Yan-Bin
Feng, Dong-Fu
Li, Zhi-Qiang
Jiang, Pu-Cha
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-11-69
- URN
-
urn:nbn:de:1111-2016041444975
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chu, Sheng-Hua
- Ma, Yan-Bin
- Feng, Dong-Fu
- Li, Zhi-Qiang
- Jiang, Pu-Cha
- SpringerLink (Online service)
Ähnliche Objekte (12)
Accelerated hyperfractionation plus temozolomide in glioblastoma
Predictive value of MRI features on glioblastoma
Temozolomide promotes genomic and phenotypic changes in glioblastoma cells
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Considering the experimental use of temozolomide in glioblastoma research
Predictive value of tumor recurrence using urinary vascular endothelial factor levels in patients receiving radiation therapy for Glioblastoma Multiforme (GBM)
Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation
Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres
One-carbon-mediated purine synthesis underlies temozolomide resistance in glioblastoma
Inhibition of gap junctions sensitizes primary glioblastoma cells for temozolomide
Glioblastoma stem cells deliver ABCB4 transcribed by ATF3 via exosomes conferring glioblastoma resistance to temozolomide
Markedly divergent effects of Ouabain on a Temozolomide-resistant (T98G) vs. a Temozolomide-sensitive (LN229) Glioblastoma cell line
Accelerated hyperfractionation plus temozolomide in glioblastoma
Predictive value of MRI features on glioblastoma
Temozolomide promotes genomic and phenotypic changes in glioblastoma cells
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Considering the experimental use of temozolomide in glioblastoma research
Predictive value of tumor recurrence using urinary vascular endothelial factor levels in patients receiving radiation therapy for Glioblastoma Multiforme (GBM)
Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation
Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres
One-carbon-mediated purine synthesis underlies temozolomide resistance in glioblastoma
Inhibition of gap junctions sensitizes primary glioblastoma cells for temozolomide
Glioblastoma stem cells deliver ABCB4 transcribed by ATF3 via exosomes conferring glioblastoma resistance to temozolomide
Markedly divergent effects of Ouabain on a Temozolomide-resistant (T98G) vs. a Temozolomide-sensitive (LN229) Glioblastoma cell line
Accelerated hyperfractionation plus temozolomide in glioblastoma
Predictive value of MRI features on glioblastoma
Temozolomide promotes genomic and phenotypic changes in glioblastoma cells
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Considering the experimental use of temozolomide in glioblastoma research
Predictive value of tumor recurrence using urinary vascular endothelial factor levels in patients receiving radiation therapy for Glioblastoma Multiforme (GBM)
Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation
Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres
One-carbon-mediated purine synthesis underlies temozolomide resistance in glioblastoma
Inhibition of gap junctions sensitizes primary glioblastoma cells for temozolomide
Glioblastoma stem cells deliver ABCB4 transcribed by ATF3 via exosomes conferring glioblastoma resistance to temozolomide